X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $90,383.64 +0.08%
Ethereum $3,124.64 +1.14%
BNB $895.64 +1.24%
Optimism $0.31 +2.23%
Arbitrum $0.22 +5.09%
Solana $133.40 +0.32%
Polygon $0.22 +2.77%
Cosmos $2.18 +1.21%
Avalanche $13.36 +1.29%

Bitcoin $90,383.64 +0.08%
Ethereum $3,124.64 +1.14%
BNB $895.64 +1.24%
Optimism $0.31 +2.23%
Arbitrum $0.22 +5.09%
Solana $133.40 +0.32%
Polygon $0.22 +2.77%
Cosmos $2.18 +1.21%
Avalanche $13.36 +1.29%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed